1.Shiraishi I, Ichikawa H. Human Heterotaxy Syndrome-From Molecular Genetics to Clinical Features,Management, and Prognosis. Circulation Journal, 2012,76(9):2066-2075.
3.Van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol, 2011, 58(21): 2241-2247.
4.Zhu L, Belmont JW, Ware SM. Genetics of human heterotaxias. Eur J Hum Genet, 2006,14(1): 17-25.
5.Escobar-Diaz MC, Friedman K, Salem Y, et al. Perinatal and Infant Outcomes of Prenatal Diagnosis of Heterotaxy Syndrome (Asplenia and Polysplenia). Am J Cardiol, 2014,114(4): 612-617.
6.Gilljam T, McCrindle BW, Smallhorn JF, et al. Outcomes of left atrial isomerism over a 28-year period at a single institution. J Am Coll Cardiol, 2000, 36(3):908-916.
7.Pepes S, Zidere V, Allan LD. Prenatal diagnosis of left atrial isomerism. Heart, 2009,95(24):1974-1977.
8.McGovern E, Kelleher E, Potts JE. Predictors of poor outcome among children with heterotaxy syndrome: a retrospective review.Open Heart, 2016, 3(2):e000328.
9.Buca DIP, Khalil A, Rizzo G.Outcome of prenatally diagnosed fetal heterotaxy:systematic review and metaanalysis.Ultrasound Obstet Gynecol, 2018,51(3): 323-330.